AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $276,000 | -16.4% | 6,000 | 0.0% | 0.02% | -15.4% |
| Q2 2021 | $330,000 | +6.8% | 6,000 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $309,000 | +34.9% | 6,000 | +76.5% | 0.03% | +4.0% |
| Q1 2019 | $229,000 | -12.6% | 3,400 | 0.0% | 0.02% | -13.8% |
| Q3 2018 | $262,000 | -8.4% | 3,400 | 0.0% | 0.03% | -14.7% |
| Q2 2018 | $286,000 | +2.9% | 3,400 | 0.0% | 0.03% | -2.9% |
| Q1 2018 | $278,000 | +22.5% | 3,400 | 0.0% | 0.04% | +20.7% |
| Q3 2017 | $227,000 | +2.7% | 3,400 | 0.0% | 0.03% | -21.6% |
| Q4 2015 | $221,000 | -7.9% | 3,400 | 0.0% | 0.04% | -9.8% |
| Q3 2015 | $240,000 | -36.5% | 3,400 | 0.0% | 0.04% | -25.5% |
| Q2 2015 | $378,000 | +17.8% | 3,400 | 0.0% | 0.06% | +19.6% |
| Q1 2015 | $321,000 | -22.7% | 3,400 | -8.1% | 0.05% | -23.3% |
| Q4 2014 | $415,000 | +35.2% | 3,700 | -26.0% | 0.06% | +27.7% |
| Q3 2014 | $307,000 | +34.1% | 5,000 | 0.0% | 0.05% | +46.9% |
| Q2 2014 | $229,000 | – | 5,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |